Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)
Volume 96 | IMPE2023

IMPE 2023

Buenos Aires, Argentina
04 Mar 2023 - 07 Mar 2023

Card image cap
11th International Meeting of Pediatric Endocrinology (IMPE 2023). 4 -7 March 2023 - Buenos Aires, Argentina.

Free Communications

Adrenals and HPA Axis 1

impe0096fc6.1 | Adrenals and HPA Axis 1 | IMPE2023

Anastrozole improves height outcomes in growing children with congenital adrenal hyperplasia

Al-Rayess Heba , Wiersma Rebecca , Turner Lindsey , Palzer Elise , Hodges James , Munoz Yesica , Sarafoglou Kyriakie

Background: Hyperandrogenemia resulting in estrogen-mediated accelerated bone maturation and early growth plate fusion largely contributes to short stature in children with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Aromatase inhibitors block androgen conversion to estrogen and have been used off-label in children with short stature to improve adult height. There have been no adequately powered studies supporting the use of aromatas...

impe0096fc6.2 | Adrenals and HPA Axis 1 | IMPE2023

Inhibiting the binding of ACTH to the Melanocorticotropin receptor by peptide to block androgen production.

V Pandey Amit , Parween Shaheena , Singh Shripriya , E Flück Christa

Background: The adrenocorticotropic hormone (ACTH) is a 39 amino acid polypeptide secreted by the anterior pituitary and regulates cortisol secretion from the adrenal cortex. Cortisol has a negative feedback mechanism and regulates the biosynthesis and secretion of ACTH. Excess of ACTH is associated with a wide range of diseases including congenital adrenal hyperplasia (CAH). Classic CAH due to the 21-hydroxylase (CYP21A2) deficiency causes a reduction or loss...

impe0096fc6.3 | Adrenals and HPA Axis 1 | IMPE2023

Disruption of Pediatric Cushing Syndrome Evaluations by Heterophile Antibodies interfering with an Adrenocorticotropic Hormone (ACTH) Assay

Jumani Sanjay , Yanovski Jack , Nieman Lynnette , Cole Justine , Harb Roa , Gun Hasan , Lightbourne Marissa

Contemporary ACTH assays have variable susceptibility to interference by endogenous antibodies, particularly heterophile antibodies, leading potentially to unnecessary investigations1-6. Often, determining the cause of the spurious ACTH results is impossible beyond identifying the presence of interference of heterophile antibodies6. Here we describe two cases of Cushing Syndrome due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD) whose evaluat...

impe0096fc6.4 | Adrenals and HPA Axis 1 | IMPE2023

Development of a drug screening method for molecular targeted therapy of MIRAGE syndrome

Narumi Satoshi , Tanase-Nakao Kanako

Context: MIRAGE syndrome (OMIM #617053) is a multiorgan disorder including hypoplasia of the adrenal glands and gonads (Narumi S et al., Nat Genet 2016). The syndrome is caused by heterozygous pathogenic SAMD9 variants with potent growth-inhibitory activity. There is no effective treatment for the syndrome, and approximately 40% of documented cases die before age 3.Objective: We aimed to establish a screening me...